Skip to main content
. 2022 Dec 30;11(1):103. doi: 10.3390/biomedicines11010103

Figure 3.

Figure 3

Course of visual acuity after gene therapy with voretigene neparvovec. Course of best corrected visual acuity (BCVA) of each treated eye is shown ranging from a minimal postoperative follow up time of 6 months (n = 8) up to 32 months (n = 1).